| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/1998 | US5776952 Method and composition for topical therapy of back pain and muscle tension |
| 07/07/1998 | US5776951 Anticholesterol agent |
| 07/07/1998 | US5776950 Cycloanthelmintic inhibitors |
| 07/07/1998 | US5776949 2-(1H) quinolinone compounds |
| 07/07/1998 | US5776947 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock |
| 07/07/1998 | US5776946 Peripheral benzodiazepine receptor ligands as antiinflammatory agents |
| 07/07/1998 | US5776943 Rapamycin metabolites |
| 07/07/1998 | US5776940 Compounds for treatment of septic shock, antiinflammatory and antiallergens |
| 07/07/1998 | US5776939 Drug resistance and multidrug resistance modulators |
| 07/07/1998 | US5776937 Adhesion receptor antagonists |
| 07/07/1998 | US5776935 Antagonists of strychnine-insensitive glycine site of n-methylaspartic acid receptor |
| 07/07/1998 | US5776933 Method of inhibiting protease |
| 07/07/1998 | US5776932 1,3,5-tribsubstituted indazole derivatives, processes for preparing, and for pharmacological treatment therewith |
| 07/07/1998 | US5776930 Pharmaceutical preparation |
| 07/07/1998 | US5776928 Method for treating dyskinesias with olanzapine |
| 07/07/1998 | US5776926 Cefixime composition |
| 07/07/1998 | US5776925 Texaphyrins |
| 07/07/1998 | US5776923 Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
| 07/07/1998 | US5776922 Antiallergens, antiinflammatory agents, cataract and antiischemic organ disease |
| 07/07/1998 | US5776921 Steroids and derivatives for immunology and cell proliferation and differentiation |
| 07/07/1998 | US5776920 Using mixture of salicylic and lactic acid and urea |
| 07/07/1998 | US5776919 Potentiators of antimicrobial activity |
| 07/07/1998 | US5776918 Salicylic acid, amiodarone and topical carrier |
| 07/07/1998 | US5776917 Compositions for regulating skin wrinkles and/or skin atrophy |
| 07/07/1998 | US5776916 Applying mixture of carbachol and betablocker |
| 07/07/1998 | US5776914 Storage, preservation of erythrocytes |
| 07/07/1998 | US5776913 Therapeutic diet for metabolic abnormalities found in animals with lymphoma |
| 07/07/1998 | US5776912 Lipophilic oligosaccharide antibiotic compositions |
| 07/07/1998 | US5776911 Use of (S)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia |
| 07/07/1998 | US5776910 Dna molecule codes and fc receptors |
| 07/07/1998 | US5776906 Method for promoting fat-degradation in fat cells |
| 07/07/1998 | US5776904 Dispersion preparation |
| 07/07/1998 | US5776891 Polyester |
| 07/07/1998 | US5776887 Diabetic nutritional product having controlled absorption of carbohydrate |
| 07/07/1998 | US5776783 Method of monitoring therapeutic agent consumption |
| 07/07/1998 | US5776765 Isolation of isomer from racemic mixture |
| 07/07/1998 | US5776743 Method of sensitizing tumor cells with adenovirus E1A |
| 07/07/1998 | US5776732 Isolated, purified polynucleotide sequence encoding a polypeptide |
| 07/07/1998 | US5776731 DNA encoding type-I interleukin-I receptor-like protein designated 2F1 |
| 07/07/1998 | US5776699 Method of identifying negative hormone and/or antagonist activities |
| 07/07/1998 | US5776505 Pharmaceutical combination preparation comprising ketoprofen |
| 07/07/1998 | US5776504 Magnesium taurate for prevention and treatment of pre-eclampsia/eclampsia |
| 07/07/1998 | US5776503 Mixture of amino acids to minimize metabolic acidosis |
| 07/07/1998 | US5776499 Process for preparing a clodronate preparation |
| 07/07/1998 | US5776498 Nutritional supplement, therapeutic and prophylactic agent |
| 07/07/1998 | US5776495 Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
| 07/07/1998 | US5776492 Rapidly disintegrating medicinal form of tramadol or a tramadol salt |
| 07/07/1998 | US5776489 Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
| 07/07/1998 | US5776485 Nonionic polyacrylamide with high molecular weight for drug delivery |
| 07/07/1998 | US5776484 Analgesic anti-inflammatory adhesive plaster |
| 07/07/1998 | US5776482 Tetrahydroquinoline analogues for use in glaucoma treatment |
| 07/07/1998 | US5776480 Cosmetic or dermatological composition containing a mixture of ceramides for moisturizing the skin |
| 07/07/1998 | US5776470 Method of using lipid transfer proteins and lipids to reconstitute membranes |
| 07/07/1998 | US5776468 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A |
| 07/07/1998 | US5776456 Administering a polypeptide |
| 07/07/1998 | US5776455 Pharmaceutical formulations |
| 07/07/1998 | US5776433 Solutions for aerosols and propellants of tetrafluoroethane,heptafluoropropane and ethanol |
| 07/07/1998 | US5776432 Treating asthma |
| 07/07/1998 | US5776430 Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol |
| 07/07/1998 | US5776184 Intravasoular stent and method |
| 07/07/1998 | US5775339 Antitumor |
| 07/07/1998 | CA2163446C Pyrazolopyrimidinones for the treatment of impotence |
| 07/07/1998 | CA2133963C Novel mercaptoacetylamido pyridazo¬1,2|pyridazine, pyrazolo¬1,2|pyridazine, pyridazo¬1,2-a|¬1,2|diazepine and pyrazolo¬1,2-a|¬1,2|diazepine derivatives useful as inhibitors of enkephalinase and ace |
| 07/07/1998 | CA2117891C Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent |
| 07/07/1998 | CA2111932C Quick-drying gel-type disinfectant for hands and fingers |
| 07/07/1998 | CA2051281C Process for the preparation of triazolyl isopropanols |
| 07/07/1998 | CA2033243C Phenylethanolaminomethyltetralins |
| 07/02/1998 | WO1998028607A1 Systems and methods for quantifying photoreactions in light activated materials |
| 07/02/1998 | WO1998028442A1 Methods for detecting and inhibiting the rna component of telomerase |
| 07/02/1998 | WO1998028435A1 Plant clones containing elevated secondary metabolite levels |
| 07/02/1998 | WO1998028418A1 Tailless nuclear hormone receptor (tlx receptor) |
| 07/02/1998 | WO1998028389A1 Substance with antiobestic and cumulative visceral fat-reducing actions and use thereof |
| 07/02/1998 | WO1998028324A1 Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028323A1 Meiosis regulating compounds |
| 07/02/1998 | WO1998028319A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 07/02/1998 | WO1998028317A2 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | WO1998028316A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 07/02/1998 | WO1998028305A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028304A1 Pro-drugs and counterparts of camptothecin, their application as medicines |
| 07/02/1998 | WO1998028301A1 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 07/02/1998 | WO1998028300A1 Triazolo[4,5-d]pyrimidinyl derivatives and their use as medicaments |
| 07/02/1998 | WO1998028299A2 Imidazopyridazines |
| 07/02/1998 | WO1998028297A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists |
| 07/02/1998 | WO1998028295A1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function |
| 07/02/1998 | WO1998028294A1 A novel compound form |
| 07/02/1998 | WO1998028293A1 Indane or dihydroindole derivatives |
| 07/02/1998 | WO1998028292A1 Novel piperidine containing compounds |
| 07/02/1998 | WO1998028290A1 Indane or dihydroindole derivatives |
| 07/02/1998 | WO1998028288A1 6-thio-substituted paclitaxels |
| 07/02/1998 | WO1998028282A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 07/02/1998 | WO1998028281A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| 07/02/1998 | WO1998028276A1 Triarylethanes useful as pde iv inhibitors |
| 07/02/1998 | WO1998028275A1 Novel compounds with analgesic effect |
| 07/02/1998 | WO1998028274A1 Use of benzoylalkyl-1,2,3,6-tetrahydropyridins |
| 07/02/1998 | WO1998028273A1 Method for preparing a tetrahydropyridin derivative |
| 07/02/1998 | WO1998028272A1 Micro-particulate form of a tetrahydropyridin derivative |
| 07/02/1998 | WO1998028271A1 Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms |
| 07/02/1998 | WO1998028270A1 Novel compounds with analgesic effect |
| 07/02/1998 | WO1998028269A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 07/02/1998 | WO1998028268A2 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS |